|Chemical and physical data|
|Molar mass||367.468 g·mol−1|
|3D model (JSmol)|
5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263) is a pyrrolo[2,3-b]pyridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug. It was first identified by the EMCDDA in February 2015.
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|